| abstract |
The present invention relates to Pharmacological inhibitors technical fields, and in particular to a kind of 1 tumour immunity inhibitor of novel PD and its process for preparing medicine, the immunosuppressor are made of following parts by weight raw material：30 45 parts of 1 monoclonal antibodies of PD, 26 parts of alkaloids, 47 parts of antibiotic, 39 parts of alkylating agents, 15 parts of platinum agent, 59 parts of metabolic antagonist compositions；Wherein, alkaloid is made of one or more in taxol, vincristine, Taxotere；Antibiotic is made of one or more in epirubicin, idarubicin, mitomycin；Alkylating agent is one or both of ifosfamide, Dacarbazine；Platinum agent is one or both of cis-platinum, oxaliplatin；Metabolic antagonist is one or more in gemcitabine, cytarabine, Tegafur；Immunosuppressor provided by the present invention can block the interaction of the PD L1 molecules and the receptor on activating T cell expressed on tumour cell, and inhibit the apoptosis of activating T cell, improve the killing ability to tumour cell. |